ReviewJournal of virology2025
Human metapneumovirus: understanding the molecular mechanisms and pathology of infection.
Review in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Reduced expression of human metapneumovirus matrix protein impacts virus assembly and ribonucleoprotein localization.Journal of virology · 2026Article
- Twenty-five years of human metapneumovirus research.Clinical microbiology reviews · 2026Review
- Target-Based Antiviral Drug Development Against Human Respiratory Viruses.Pathogens (Basel, Switzerland) · 2026Review
- Lung Microbiome Diversity, Infection Dynamics, and Microbe-Mediated Cross-Protection.MicrobiologyOpen · 2026Review
- Avian Metapneumovirus: Virology, Epidemiology, and Insights from a Comparative Analysis with Human Metapneumovirus-A Review.Biomolecules · 2026Review
- Clinical Outcomes and Molecular Epidemiology of Human Metapneumovirus in Romanian Hospitalized Patients.Microorganisms · 2026Article
- Molecular Evolution of theMicroorganisms · 2026Article
- Genetic and epidemiological characteristics of the spread of human metapneumovirus in Bulgaria, 2023-2025.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Human metapneumovirus (HMPV) is a common and globally prevalent respiratory virus that can cause clinical symptoms ranging from mild respiratory illness to severe bronchiolitis and pneumonia, with substantial morbidity and mortality. HMPV accounts for a substantial health care and economic burden, with high hospitalization rates. Consequently, there is an urgent need for effective preventive and therapeutic interventions. The development of these interventions requires comprehensive knowledge of the virus's biology, including characteristics, epidemiology, evolution, virus-host interactions, and host immune responses. Despite being discovered nearly 25 years ago, HMPV has remained relatively underrecognized, resulting in limited awareness of its true impact and delays in the development of treatment options. Recent studies have demonstrated the emergence of novel genotypes and provided more insight into viral replication, spread, and host immune responses. In this review, we highlight the clinical significance of HMPV and explore the molecular mechanisms the virus employs throughout the course of an infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.